Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
12.07B | 11.74B | 9.75B | 9.68B | 8.49B | Gross Profit |
12.07B | 11.90B | 9.75B | 9.68B | 8.49B | EBIT |
0.00 | 6.88B | 7.92B | 4.94B | 2.96B | EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Income Common Stockholders |
5.06B | 4.93B | 3.59B | 3.83B | 2.27B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
50.64B | 51.36B | 62.70B | 49.89B | 39.20B | Total Assets |
623.36B | 584.70B | 594.84B | 570.35B | 552.16B | Total Debt |
0.00 | 188.27B | 190.28B | 183.66B | 182.48B | Net Debt |
-50.64B | -52.53B | 127.58B | 133.77B | 143.28B | Total Liabilities |
590.92B | 553.48B | 563.44B | 536.85B | 518.42B | Stockholders Equity |
32.44B | 31.23B | 31.40B | 33.49B | 33.73B |
Cash Flow | Free Cash Flow | |||
383.00M | -6.97B | 21.57B | 17.17B | -1.83B | Operating Cash Flow |
906.00M | -6.47B | 21.98B | 17.59B | -1.34B | Investing Cash Flow |
-2.92B | -535.00M | -629.00M | -380.00M | -1.01B | Financing Cash Flow |
-2.35B | -4.01B | 17.86B | -4.93B | -2.65B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $39.10B | 7.17 | 16.39% | 4.19% | 12.29% | 4.54% | |
76 Outperform | $52.46B | 8.24 | 20.84% | 7.36% | -7.01% | 15.18% | |
76 Outperform | $50.07B | 10.55 | 9.95% | 4.36% | 36.29% | -19.79% | |
73 Outperform | $60.47B | 11.12 | 11.10% | 4.16% | 7.24% | 7.51% | |
71 Outperform | $50.43B | 9.30 | 8.56% | 2.70% | 13.63% | 27.77% | |
70 Neutral | $57.38B | 9.73 | 11.00% | 5.41% | 5.59% | 15.52% | |
64 Neutral | $12.70B | 9.08 | 9.19% | 4.89% | 16.29% | -8.64% |